Aytu BioPharma, Inc. - Common Stock (NQ:AYTU)

2.100 +0.030 (+1.45%)

Delayed Quote Updated: 1:37 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Aytu BioPharma, Inc. - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Why Chimerix Is Trading Higher By Over 19%, Here Are 53 Stocks Moving In Monday's Mid-Day Session ↗

August 29, 2022

Gainers Advanced Human Imaging Limited (NASDAQ: AHI) shares jumped 53% to $1.04. Advanced Human Imaging announced Sunday it signed a Master Services Agreement with Estonia-based Activate Health OÜ.

Via Benzinga

Aytu BioPharma to Participate in September 2022 Investor Conferences

August 24, 2022

Via ACCESSWIRE

Aytu BioPharma Announces Issuance of Its First Patent for AR101/Enzastaurin

August 16, 2022

Via ACCESSWIRE

Aytu BioPharma Plans To Divest / Discontinue Non Core Assets ↗

May 17, 2022

Via Benzinga

Aytu BioPharma Announces Closing of $10.0 Million Registered Public Offering

August 15, 2022

Via ACCESSWIRE

Stocks That Hit 52-Week Lows On Wednesday ↗

August 10, 2022

During Wednesday, 52 stocks hit new 52-week lows.

Via Benzinga

Dow Drops Over 100 Points; Verona Pharma Shares Jump ↗

August 09, 2022

U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping more than 100 points on Tuesday.

Via Benzinga

Why Avalo Therapeutics Surged 32%; Here Are 111 Biggest Movers From Yesterday ↗

August 10, 2022

Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) gained 60.1% to settle at $7.27 on Tuesday after the company was granted US patent for an air treatment system and method.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

August 09, 2022

Via Benzinga

Why Verona Pharma Is Trading Higher By Around 84%, Here Are 85 Stocks Moving In Tuesday's Mid-Day Session ↗

August 09, 2022

Gainers Verona Pharma plc (NASDAQ: VRNA) shares jumped 83.6% to $12.70 after the company announced ensifentrine met its primary endpoint and secondary endpoints in the Phase 3 ENHANCE-2 trial for COPD....

Via Benzinga

Nasdaq Tumbles 1.5%; BBQ Holdings Shares Spike Higher ↗

August 09, 2022

U.S. stocks traded lower midway through trading, with the Nasdaq dropping around 1.5% on Tuesday.

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

August 09, 2022

On Tuesday, 73 companies hit new 52-week lows.

Via Benzinga

Aytu BioPharma Announces Pricing of Public Offering

August 09, 2022

Via ACCESSWIRE

Biotech Daily: Regulatory Setback For CorMedix, Mersana & GSK In Cancer Pact, BARDA Funding For Opioid Overdose Hopeful ↗

August 09, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

August 09, 2022

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

August 09, 2022

We're starting off Tuesday with a breakdown of the biggest pre-market stock movers traders will want to keep an eye on today!

Via InvestorPlace

Why Is BIMI International Medical Higher By Around 70%: Here Are 38 Stocks Moving Premarket ↗

August 09, 2022

Gainers BIMI International Medical Inc. (NASDAQ: BIMI) shares rose 69.6% to $1.04 in pre-market trading after Fnu Oudom reported a stake of 44% in the company in 13D.

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

August 08, 2022

Via Benzinga

Aytu BioPharma Announces Launch of Public Offering

August 08, 2022

Via ACCESSWIRE

12 Health Care Stocks Moving In Monday's After-Market Session ↗

August 01, 2022

Gainers Conformis (NASDAQ:CFMS) shares moved upwards by 13.2% to $0.29 during Monday's after-market session. The company's market cap stands at $53.5 million.

Via Benzinga

Aytu BioPharma to Participate in the Canaccord Genuity 42nd Annual Growth Conference

July 26, 2022

Via ACCESSWIRE

Aytu BioPharma to Participate in the Canaccord Genuity 42nd Annual Growth Conference

July 26, 2022

ENGLEWOOD, CO / ACCESSWIRE / July 26, 2022 / Aytu BioPharma, Inc. (the "Company") (NASDAQ:AYTU), a pharmaceutical company focused on developing and commercializing novel therapeutics, today announced...

From Aytu BioPharma, Inc.

Via AccessWire

Recap of Wednesday's Biotech Catalysts - End of The Day Summary ↗

July 20, 2022

Via Benzinga

Aytu BioPharma Commences Late-Stage Genetic Disorder Study ↗

July 20, 2022

Aytu BioPharma (NASDAQ: AYTU) has initiated the global Phase 3 PREVEnt clinical trial of Enzastaurin (AR101) for the treatment of patients with COL3A1-positive Vascular Ehlers-Danlos Syndrome (VEDS).

Via Benzinga

Aytu BioPharma Announces Initiation of the AR101 PREVEnt Trial for the Treatment of Vascular Ehlers-Danlos Syndrome

July 20, 2022

Via ACCESSWIRE

Aytu BioPharma Announces Initiation of the AR101 PREVEnt Trial for the Treatment of Vascular Ehlers-Danlos Syndrome

July 20, 2022

ENGLEWOOD, CO / ACCESSWIRE / July 20, 2022 / Aytu BioPharma, Inc. (NASDAQ:AYTU), a pharmaceutical company focused on developing and commercializing novel therapeutics, today announced the initiation of...

From Aytu BioPharma, Inc.

Via AccessWire

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

July 06, 2022

Via Benzinga

Akerna Shares Dip 53%, Here's 78 Biggest Movers From Yesterday ↗

July 01, 2022

Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) surged 77.4% to close at $1.11 on Thursday after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase...

Via Benzinga

Aytu BioPharma Announces the Appointment of Vivian Liu to the Company's Board of Directors

June 29, 2022

ENGLEWOOD, CO / ACCESSWIRE / June 29, 2022 / Aytu BioPharma, Inc. (NASDAQ:AYTU), a pharmaceutical company focused on developing and commercializing novel therapeutics, today announced the appointment...

From Aytu BioPharma, Inc.

Via AccessWire

Aytu BioPharma to Participate in the Lytham Partners Summer 2022 Investor Conference

June 13, 2022

ENGLEWOOD, CO / ACCESSWIRE / June 13, 2022 / Aytu BioPharma, Inc. (NASDAQ:AYTU), a pharmaceutical company focused on developing and commercializing novel therapeutics, today announced that the company...

From Aytu BioPharma, Inc.

Via AccessWire

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.